Matthew Kyle Labriola (Matthew Labriola, Matthew K Labriola)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Cross Sectional

Childhood Cancer

Top Venues

Journal for immunotherapy of cancer

Research square

This page only lists publications with an associated author ORCID identifier.

Publications

Tanya Barauskas Dorff, Zeynep Zengin, Nicholas Henderson, Joseph Park, Alicia Ali, Charles Nguyen, Clara Hwang, Pedro C Barata, Mehmet Bilen, Laura S Graham, George Mo, Deepak Kilari, Abhishek Tripathi, Matthew Kyle Labriola, Shoshana Rothstein, Rohan Garje, Vadim Koshkin, Vaibhav Patel, Michael T Schweizer, Andrew J Armstrong, Rana R McKay, Ajjai Alva
Clinical implications of AR alterations in advanced prostate cancer: A multi-institutional collaboration. Research square (2023)
Matthew Kyle Labriola, Daniel J George
Setting a new standard for long-term survival in metastatic kidney cancer. Cancer 128 (11) (2022)
Maitri Kalra, Elizabeth Henry, Kelly E McCann, Meghan S Karuturi, Jean G Bustamante Alvarez, Amanda Parkes, Robert Wesolowski, Mei Wei, Sarah S Mougalian, Gregory Durm, Angel Qin, Caitlin A Schonewolf, Meghna S Trivedi, Avan J Armaghani, Frederick H Wilson, Wade T Iams, Anita A Turk, Praveen Vikas, Michael Cecchini, Sam Lubner, Priyadarshini Pathak, Kristen Spencer, Vadim S Koshkin, Matthew Kyle Labriola, Catherine Handy Marshall, Kathryn E Beckermann, null null, Marina N Sharifi, Anthony C Bejjani, Varsha Hotchandani, Samir Housri, Nadine Housri
Making National Cancer Institute-Designated Comprehensive Cancer Center Knowledge Accessible to Community Oncologists via an Online Tumor Board: Longitudinal Observational Study. JMIR cancer 8 (2) (2022)
Landon C Brown, Jason Zhu, Kunal Desai, Emily Kinsey, Chester Kao, Yong Hee Lee, Sarabjot Pabla, Matthew Kyle Labriola, Jennifer Tran, Konstantin H Dragnev, Laura J Tafe, Farshid Dayyani, Rajan T Gupta, Shannon McCall, Daniel J George, Sean T Glenn, Mary K Nesline, Saby George, Matthew Zibelman, Carl Morrison, Moshe C Ornstein, Tian Zhang
Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor response in metastatic renal cell carcinoma. Journal for immunotherapy of cancer 10 (10) (2022)
Landon C Brown, Matthew D Tucker, Ramy Sedhom, Eric B Schwartz, Jason Zhu, Chester Kao, Matthew Kyle Labriola, Rajan T Gupta, Daniele Marin, Yuan Wu, Santosh Gupta, Tian Zhang, Michael R Harrison, Daniel J George, Ajjai Alva, Emmanuel S Antonarakis, Andrew J Armstrong
LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types. Journal for immunotherapy of cancer 9 (3) (2021)
Matthew Kyle Labriola, Jason Zhu, Rajan T Gupta, Shannon McCall, Jennifer Jackson, Eric F Kong, James R White, Gustavo Cerqueira, Kelly Gerding, John K Simmons, Daniel George, Tian Zhang
Characterization of tumor mutation burden, PD-L1 and DNA repair genes to assess relationship to immune checkpoint inhibitors response in metastatic renal cell carcinoma. Journal for immunotherapy of cancer 8 (1) (2021)